Načítá se...
The BRAF(V600E) mutation: what is it really orchestrating in thyroid cancer?
BRAF(V600E) is a constitutively active onco-kinase and is the most common genetic alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well, albeit at a lower frequency. The BRAF(V600E) mutation in some studies has been significantly associated with extra-thyroidal...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals LLC
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3074562/ https://ncbi.nlm.nih.gov/pubmed/21321384 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|